Breaking News Instant updates and real-time market news.

ULTA

Ulta Beauty

$174.41 /

-13.72 (-7.29%)

06:18
03/30/20
03/30
06:18
03/30/20
06:18

Ulta Beauty upgraded to Overweight from Equal Weight at Wells Fargo

Wells Fargo analyst Ike Boruchow upgraded Ulta Beauty to Overweight from Equal Weight with a price target of $250, up from $205. While the COVID-19 headwinds are extremely severe and the downturn will likely be much deeper, the analyst says he believes it will be shorter in duration than past recessions, setting the group up for a strong 2021 recovery. He is near-term cautious, longer-term bullish, with a clear bias towards higher quality names with more downside risk across the companies in a more difficult financial position.

  • 14

    Sep

ULTA Ulta Beauty
$174.41 /

-13.72 (-7.29%)

03/24/20 Oppenheimer
Ulta Beauty price target lowered to $220 from $275 at Oppenheimer
03/20/20 Citi
Ulta Beauty upgraded to Buy from Neutral at Citi
03/19/20 Nomura Instinet
Ulta Beauty price target lowered to $195 from $225 at Nomura Instinet
03/13/20 BMO Capital
Ulta Beauty price target lowered to $235 from $285 at BMO Capital

TODAY'S FREE FLY STORIES

Hot Stocks
Sony to pay A$3.5M fine for misleading PlayStation players about refunds » 13:07
06/05/20
06/05
13:07
06/05/20
13:07
SNE

Sony

$67.19 /

+1 (+1.51%)

The Australian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNE Sony
$67.19 /

+1 (+1.51%)

SNE Sony
$67.19 /

+1 (+1.51%)

05/13/20 Macquarie
Sony downgraded to Neutral from Outperform at Macquarie
03/18/20
Fly Intel: Top five analyst initiations
03/18/20 Oppenheimer
Oppenheimer bullish on Sony, initiates with an Outperform
03/17/20 Oppenheimer
Sony initiated with an Outperform at Oppenheimer
SNE Sony
$67.19 /

+1 (+1.51%)

SNE Sony
$67.19 /

+1 (+1.51%)

SNE Sony
$67.19 /

+1 (+1.51%)

SNE Sony
$67.19 /

+1 (+1.51%)

Options
Caesars call volume above normal and directionally bullish » 13:05
06/05/20
06/05
13:05
06/05/20
13:05
CZR

Caesars

$12.43 /

+0.29 (+2.39%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CZR Caesars
$12.43 /

+0.29 (+2.39%)

CZR Caesars
$12.43 /

+0.29 (+2.39%)

06/04/20 Deutsche Bank
Caesars price target raised to $12 from $11 at Deutsche Bank
06/02/20 Nomura Instinet
Eldorado Resorts price target raised to $34 from $12.50 at Nomura Instinet
05/21/20 BofA
MGM Resorts downgraded to Underperform from Neutral at BofA
05/12/20 Deutsche Bank
Caesars price target lowered to $11 from $13 at Deutsche Bank
CZR Caesars
$12.43 /

+0.29 (+2.39%)

CZR Caesars
$12.43 /

+0.29 (+2.39%)

CZR Caesars
$12.43 /

+0.29 (+2.39%)

CZR Caesars
$12.43 /

+0.29 (+2.39%)

Recommendations
JPMorgan backs Underweight on Remy Cointreau after FY20 reuslts » 13:04
06/05/20
06/05
13:04
06/05/20
13:04
REMYY

Remy Cointreau

$0.00 /

+ (+0.00%)

JPMorgan analyst Celine…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REMYY Remy Cointreau
$0.00 /

+ (+0.00%)

REMYY Remy Cointreau
$0.00 /

+ (+0.00%)

10:38 Today Morgan Stanley
Remy Cointreau price target raised to EUR 92 from EUR 85 at Morgan Stanley
06/04/20 Societe Generale
Remy Cointreau price target raised to EUR 102 from EUR 100 at Societe Generale
05/18/20 Goldman Sachs
Remy Cointreau downgraded to Neutral from Buy at Goldman Sachs
04/30/20 Morgan Stanley
Remy Cointreau price target lowered to EUR 85 from EUR 87 at Morgan Stanley
REMYY Remy Cointreau
$0.00 /

+ (+0.00%)

Hot Stocks
Baker Hughes reports U.S. rig count down 17 to 284 rigs » 13:03
06/05/20
06/05
13:03
06/05/20
13:03
BKR

Baker Hughes

$18.10 /

+0.945 (+5.51%)

Baker Hughes reports that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BKR Baker Hughes
$18.10 /

+0.945 (+5.51%)

BKR Baker Hughes
$18.10 /

+0.945 (+5.51%)

05/29/20 Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
BKR Baker Hughes
$18.10 /

+0.945 (+5.51%)

BKR Baker Hughes
$18.10 /

+0.945 (+5.51%)

BKR Baker Hughes
$18.10 /

+0.945 (+5.51%)

General news
Baker-Hughes Rig Count N. Amer. data reported » 13:03
06/05/20
06/05
13:03
06/05/20
13:03

Week of 6/5 Baker-Hughes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
JPMorgan backs Neutral on Pennon after FY20 results » 13:02
06/05/20
06/05
13:02
06/05/20
13:02
PEGRY

Pennon Group

$0.00 /

+ (+0.00%)

JPMorgan analyst Javier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PEGRY Pennon Group
$0.00 /

+ (+0.00%)

11:02 Today Deutsche Bank
Deutsche Bank backs Buy on Pennon after FY20 results
04/14/20 Credit Suisse
Pennon Group upgraded to Neutral from Underperform at Credit Suisse
03/23/20 Goldman Sachs
Pennon Group downgraded to Neutral from Buy at Goldman Sachs
Hot Stocks
Baker Hughes reports U.S. rig count down 17 to 284 rigs  13:02
06/05/20
06/05
13:02
06/05/20
13:02
BKR

Baker Hughes

$18.10 /

+0.95 (+5.54%)

 
ShowHide Related Items >><<
BKR Baker Hughes
$18.10 /

+0.95 (+5.54%)

BKR Baker Hughes
$18.10 /

+0.95 (+5.54%)

05/29/20 Northland
Baker Hughes initiated with a Market Perform at Northland
04/23/20 Citi
Baker Hughes price target raised to $16 from $14 at Citi
04/05/20 Bernstein
Baker Hughes upgraded to Outperform from Underperform at Bernstein
03/31/20
Fly Intel: Top five analyst downgrades
BKR Baker Hughes
$18.10 /

+0.95 (+5.54%)

BKR Baker Hughes
$18.10 /

+0.95 (+5.54%)

BKR Baker Hughes
$18.10 /

+0.95 (+5.54%)

Recommendations
JPMorgan backs Overweight on Novo Nordisk after STEP data » 13:01
06/05/20
06/05
13:01
06/05/20
13:01
NVO

Novo Nordisk

$64.05 /

-0.32 (-0.50%)

JPMorgan analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NVO Novo Nordisk
$64.05 /

-0.32 (-0.50%)

NVO Novo Nordisk
$64.05 /

-0.32 (-0.50%)

05/18/20 Morgan Stanley
Novo Nordisk price target raised to DKK 435 from DKK 425 at Morgan Stanley
05/13/20 JPMorgan
Novo Nordisk price target raised to DKK 480 from DKK 460 at JPMorgan
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 UBS
Novo Nordisk downgraded to Neutral from Buy at UBS
NVO Novo Nordisk
$64.05 /

-0.32 (-0.50%)

NVO Novo Nordisk
$64.05 /

-0.32 (-0.50%)

NVO Novo Nordisk
$64.05 /

-0.32 (-0.50%)

Conference/Events
Ultragenyx participates in a conference call with Cowen » 12:55
06/05/20
06/05
12:55
06/05/20
12:55
RARE

Ultragenyx

$70.29 /

+0.52 (+0.75%)

Biotech Analyst Werber…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RARE Ultragenyx
$70.29 /

+0.52 (+0.75%)

RARE Ultragenyx
$70.29 /

+0.52 (+0.75%)

05/18/20 Stifel
Ultragenyx price target raised to $82 from $70 at Stifel
05/15/20 Piper Sandler
Piper continues to like Ultragenyx setup after DTX-401 data
05/13/20 Piper Sandler
Ultragenyx DTX-301 update 'incrementally positive,' says Piper Sandler
01/10/20 SunTrust
Ultragenyx price target raised to $80 from $75 at SunTrust
RARE Ultragenyx
$70.29 /

+0.52 (+0.75%)

Initiation
LEG Immobilien reinstated with an Overweight at JPMorgan » 12:54
06/05/20
06/05
12:54
06/05/20
12:54
LEGIF

LEG Immobilien

$0.00 /

+ (+0.00%)

JPMorgan analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEGIF LEG Immobilien
$0.00 /

+ (+0.00%)

05/12/20 Deutsche Bank
Deutsche Bank backs Buy on LEG Immobilien after 'strong' Q1 results
05/12/20 UBS
UBS backs Buy on LEG Immobilien after Q1 results
04/09/20 HSBC
LEG Immobilien price target lowered to EUR 115 from EUR 123 at HSBC
03/11/20 Barclays
Barclays reiterates Underweight on LEG Immobilien after FY19 results
Recommendations
HelloFresh remains top pick in media space, says JPMorgan » 12:53
06/05/20
06/05
12:53
06/05/20
12:53
HLFFF

HelloFresh

$0.00 /

+ (+0.00%)

JPMorgan analyst Marcus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HLFFF HelloFresh
$0.00 /

+ (+0.00%)

11:19 Today Barclays
Barclays increases upside valuation on HelloFresh
05/15/20 Morgan Stanley
HelloFresh downgraded to Equal Weight from Overweight at Morgan Stanley
05/13/20 JPMorgan
HelloFresh price target raised to EUR 50 from EUR 45 at JPMorgan
05/06/20 Barclays
HelloFresh price target raised to EUR 40 from EUR 33 at Barclays
Recommendations
JPMorgan backs Neutral on GN Store Nord after management meeting » 12:52
06/05/20
06/05
12:52
06/05/20
12:52
GGNDF

GN Store Nord

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GGNDF GN Store Nord
$0.00 /

+ (+0.00%)

05/22/20 UBS
GN Store Nord price target raised to DKK 340 from DKK 320 at UBS
04/30/20 JPMorgan
GN Store Nord price target lowered to DKK 310 from DKK 365 at JPMorgan
04/24/20 JPMorgan
GN Store Nord price target raised to DKK 365 from DKK 324 at JPMorgan
04/17/20 Goldman Sachs
GN Store Nord downgraded to Neutral from Buy at Goldman Sachs
Recommendations
JPMorgan backs Neutral on Dialog Semiconductor » 12:50
06/05/20
06/05
12:50
06/05/20
12:50
DLGNF

Dialog Semiconductor

$0.00 /

+ (+0.00%)

JPMorgan analyst Sandeep…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

05/21/20 Cowen
Dialog Semiconductor initiated with an Outperform at Cowen
05/07/20 UBS
Dialog Semiconductor price target raised to EUR 38 from EUR 31 at UBS
05/07/20 Deutsche Bank
Dialog Semiconductor price target raised to EUR 42 from EUR 35 at Deutsche Bank
05/07/20 JPMorgan
Dialog Semiconductor price target raised to EUR 33 from EUR 32 at JPMorgan
DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

DLGNF Dialog Semiconductor
$0.00 /

+ (+0.00%)

Recommendations
JPMorgan backs Overweight on Deutsche Wohnen » 12:48
06/05/20
06/05
12:48
06/05/20
12:48
DTCWY

Deutsche Wohnen

$0.00 /

+ (+0.00%)

JPMorgan analyst Neil…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DTCWY Deutsche Wohnen
$0.00 /

+ (+0.00%)

05/27/20 Deutsche Bank
Deutsche Wohnen price target raised to EUR 60 from EUR 42 at Deutsche Bank
05/15/20 RBC Capital
Deutsche Wohnen price target raised to EUR 44 from EUR 42 at RBC Capital
05/11/20 Morgan Stanley
Deutsche Wohnen price target raised to EUR 40 from EUR 37 at Morgan Stanley
04/20/20 Jefferies
Deutsche Wohnen downgraded to Hold from Buy at Jefferies
Hot Stocks
Mack-Cali Realty modifies slate of director nominees in response to feedback » 12:45
06/05/20
06/05
12:45
06/05/20
12:45
CLI

Mack-Cali Realty

$18.36 /

+1.305 (+7.65%)

Mack-Cali Realty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

03/25/20 Evercore ISI
Mack-Cali Realty downgraded to In Line from Outperform at Evercore ISI
01/07/20 Stifel
Mack-Cali Realty downgraded to Hold from Buy at Stifel
01/06/20 Evercore ISI
Mack-Cali Realty upgraded to Outperform from In Line at Evercore ISI
12/20/19 Citi
UDR combination with Mack-Cali Realty is unlikely, says Citi
CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

CLI Mack-Cali Realty
$18.36 /

+1.305 (+7.65%)

General news
Week of 6/5 Baker-Hughes Rig Count to be released at 13:00  12:45
06/05/20
06/05
12:45
06/05/20
12:45
 
Recommendations
Dollarama price target raised to C$44 from C$37 at Canaccord » 12:41
06/05/20
06/05
12:41
06/05/20
12:41
DLMAF

Dollarama

$0.00 /

+ (+0.00%)

Canaccord analyst Derek…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLMAF Dollarama
$0.00 /

+ (+0.00%)

06/03/20 National Bank
Dollarama price target raised to C$50 from C$45 at National Bank
04/02/20 RBC Capital
Dollarama price target lowered to C$55 from C$56 at RBC Capital
04/02/20 BMO Capital
Dollarama price target lowered to C$45 from C$50 at BMO Capital
04/02/20 CIBC
Dollarama price target lowered to C$44 from C$48 at CIBC
Options
Marketwide volume on pace for new record over 50M contacts » 12:40
06/05/20
06/05
12:40
06/05/20
12:40
SPY

SPDR S&P 500 ETF Trust

$319.73 /

+8.43 (+2.71%)

Marketwide volume on pace…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

SPY SPDR S&P 500 ETF Trust
$319.73 /

+8.43 (+2.71%)

Recommendations
UBS backs Buy on Orange after denying intention to bid for Masmovil » 12:39
06/05/20
06/05
12:39
06/05/20
12:39
ORAN

Orange SA

$12.91 /

+0.3838 (+3.06%)

UBS analyst Giovanni…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORAN Orange SA
$12.91 /

+0.3838 (+3.06%)

ORAN Orange SA
$12.91 /

+0.3838 (+3.06%)

04/09/20 Morgan Stanley
Orange SA price target lowered to EUR 12 from EUR 12.50 at Morgan Stanley
03/27/20 Bryan Garnier
Orange SA upgraded to Buy from Neutral at Bryan Garnier
03/19/20 Goldman Sachs
Orange SA upgraded to Buy from Neutral at Goldman Sachs
03/16/20 BofA
Orange SA upgraded to Buy from Neutral at BofA
ORAN Orange SA
$12.91 /

+0.3838 (+3.06%)

Recommendations
UBS reiterates Buy on BP » 12:37
06/05/20
06/05
12:37
06/05/20
12:37
BP

BP

$27.65 /

+1.96 (+7.63%)

UBS analyst Jon Rigby…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

12:34 Today UBS
UBS backs Buy on Premier Oil after revised terms for BP assets
06/02/20 Wolfe Research
BP upgraded to Outperform from Peer Perform at Wolfe Research
05/28/20 Societe Generale
BP downgraded to Hold from Buy at Societe Generale
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

BP BP
$27.65 /

+1.96 (+7.63%)

General news
Fauci 'cautiously optimistic' at least one Phase 3 vaccine trial starts in July » 12:36
06/05/20
06/05
12:36
06/05/20
12:36
SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$319.72 /

+8.42 (+2.70%)

, MRNA

Moderna

$57.29 /

-3.31 (-5.46%)

, JNJ

Johnson & Johnson

$148.84 /

+2.18 (+1.49%)

, MRK

Merck

$82.61 /

+1.06 (+1.30%)

, PFE

Pfizer

$36.11 /

+0.105 (+0.29%)

, NVAX

Novavax

$46.00 /

+1.32 (+2.95%)

, INO

Inovio

$11.43 /

-0.44 (-3.71%)

, AZN

AstraZeneca

$54.12 /

+0.25 (+0.46%)

Fauci said he is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
MRNA Moderna
$57.29 /

-3.31 (-5.46%)

06/02/20 Piper Sandler
Piper reiterates Overweight rating, $100 target for Moderna after Science Day
06/02/20 BofA
Moderna price target lowered to $75 from $80 at BofA
06/01/20 Goldman Sachs
Goldman keeps $105 target after Moderna COVID vaccine moves to Phase 2
05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
04/29/20 Stephens
Catalent deal with J&J could represent $600M revenue opportunity, says Stephens
04/29/20 Barclays
Johnson & Johnson price target raised to $182 from $173 at Barclays
MRK Merck
$82.61 /

+1.06 (+1.30%)

06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
PFE Pfizer
$36.11 /

+0.105 (+0.29%)

06/01/20 Morgan Stanley
Lilly trial has higher risk and reward after Pfizer failure, says Morgan Stanley
06/01/20 Barclays
Pfizer price target lowered to $35 from $37 at Barclays
05/21/20 Piper Sandler
Gilead's filgotinib likely being underestimated by Street, says Piper Sandler
05/19/20 H.C. Wainwright
BioNTech upgraded to Buy from Neutral at H.C. Wainwright
NVAX Novavax
$46.00 /

+1.32 (+2.95%)

10:06 Today
Fly Intel: Top five analyst upgrades
09:37 Today JPMorgan
JPMorgan upgrades Novavax to Neutral despite 'shaky fundamentals'
08:16 Today B. Riley FBR
Novavax price target raised to $74 from $61 at B. Riley FBR
04:42 Today JPMorgan
Novavax upgraded to Neutral from Underweight at JPMorgan
INO Inovio
$11.43 /

-0.44 (-3.71%)

06/04/20 Cantor Fitzgerald
Inovio, Novavax COVID vaccines should not be disregarded, says Cantor
06/01/20 Piper Sandler
Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
05/21/20 Benchmark
Inovio initiated with a Buy at Benchmark
05/20/20 Roth Capital
Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

06/04/20 UBS
AstraZeneca price target raised to 7,300 GBp from 6,000 GBp at UBS
06/01/20 Piper Sandler
Aveo's tivozanib could launch in U.S. next year, says Piper Sandler
05/29/20 Guggenheim
AstraZeneca price target raised to 10,100 GBp from 9,100 GBp at Guggenheim
05/14/20 Evercore ISI
Evercore ISI says paper 'generally supportive' of AstraZeneca COVID vaccine
SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

MRNA Moderna
$57.29 /

-3.31 (-5.46%)

JNJ Johnson & Johnson
$148.84 /

+2.18 (+1.49%)

MRK Merck
$82.61 /

+1.06 (+1.30%)

PFE Pfizer
$36.11 /

+0.105 (+0.29%)

NVAX Novavax
$46.00 /

+1.32 (+2.95%)

INO Inovio
$11.43 /

-0.44 (-3.71%)

AZN AstraZeneca
$54.12 /

+0.25 (+0.46%)

SPX S&P 500
$0.00 /

+ (+0.00%)

SPY SPDR S&P 500 ETF Trust
$319.72 /

+8.42 (+2.70%)

Recommendations
UBS backs Buy on Premier Oil after revised terms for BP assets » 12:34
06/05/20
06/05
12:34
06/05/20
12:34
BP

BP

$27.62 /

+1.93 (+7.51%)

, PMOIY

Premier Oil

$0.00 /

+ (+0.00%)

UBS analyst John Delos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BP BP
$27.62 /

+1.93 (+7.51%)

PMOIY Premier Oil
$0.00 /

+ (+0.00%)

BP BP
$27.62 /

+1.93 (+7.51%)

06/02/20 Wolfe Research
BP upgraded to Outperform from Peer Perform at Wolfe Research
05/28/20 Societe Generale
BP downgraded to Hold from Buy at Societe Generale
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
05/15/20
Fly Intel: Top five analyst downgrades
PMOIY Premier Oil
$0.00 /

+ (+0.00%)

04/29/20 Berenberg
Premier Oil downgraded to Hold from Buy at Berenberg
04/01/20 Barclays
Premier Oil downgraded to Underweight from Equal Weight at Barclays
08/02/19 Barclays
Premier Oil downgraded to Equal Weight from Overweight at Barclays
BP BP
$27.62 /

+1.93 (+7.51%)

BP BP
$27.62 /

+1.93 (+7.51%)

BP BP
$27.62 /

+1.93 (+7.51%)

BP BP
$27.62 /

+1.93 (+7.51%)

Recommendations
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho » 12:33
06/05/20
06/05
12:33
06/05/20
12:33
EIDX

Eidos Therapeutics

$49.03 /

+0.08 (+0.16%)

, BBIO

BridgeBio

$28.77 /

+1.04 (+3.75%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EIDX Eidos Therapeutics
$49.03 /

+0.08 (+0.16%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

EIDX Eidos Therapeutics
$49.03 /

+0.08 (+0.16%)

05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral on timeline delays at JPMorgan
05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral from Overweight at JPMorgan
05/10/20 Piper Sandler
Piper Sandler bullish on Eidos, says AG10 opportunity remains very exciting
04/01/20 BofA
Eidos Therapeutics resumed with a Neutral at BofA
BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

05/29/20 Piper Sandler
Piper Sandler 'encouraged' by BridgeBio data presented at ASCO
05/19/20 BTIG
BridgeBio initiated with a Buy at BTIG
05/11/20 Piper Sandler
Piper Sandler says BridgeBio's Infigratinib 'attractive candidate' for ACH
04/13/20 H.C. Wainwright
BridgeBio initiated with a Buy at H.C. Wainwright
EIDX Eidos Therapeutics
$49.03 /

+0.08 (+0.16%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

BBIO BridgeBio
$28.77 /

+1.04 (+3.75%)

Syndicate
Calliditas Therapeutics opens at $19.90, IPO priced at $19.50  12:32
06/05/20
06/05
12:32
06/05/20
12:32
CALT

Calliditas Therapeutics

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
  • 05
    Jun
CALT Calliditas Therapeutics
$0.00 /

+ (+0.00%)

Recommendations
UBS backs Buy on Alcon after Cooper results » 12:27
06/05/20
06/05
12:27
06/05/20
12:27
COO

Cooper Companies

$322.48 /

+8.895 (+2.84%)

, ALC

Alcon

$63.28 /

-0.61 (-0.95%)

UBS analyst Sebastian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

ALC Alcon
$63.28 /

-0.61 (-0.95%)

COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

05/26/20 Stephens
Cooper Companies price target raised to $325 from $300 at Stephens
05/26/20 KeyBanc
Cooper Companies price target lowered to $330 from $380 at KeyBanc
05/21/20 Wells Fargo
Cooper Companies price target lowered to $329 from $388 at Wells Fargo
04/21/20 Raymond James
Cooper Companies price target lowered to $340 from $360 at Raymond James
ALC Alcon
$63.28 /

-0.61 (-0.95%)

05/21/20 JPMorgan
Alcon price target lowered to CHF 55 from CHF 58 at JPMorgan
05/14/20 UBS
Alcon price target raised to CHF 65 from CHF 60 at UBS
05/14/20 Stephens
Alcon upgraded to Overweight on quicker bounce back potential at Stephens
05/14/20 Stephens
Alcon upgraded to Overweight from Equal Weight at Stephens
COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

ALC Alcon
$63.28 /

-0.61 (-0.95%)

COO Cooper Companies
$322.48 /

+8.895 (+2.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.